Crisp: Here’s what this Amsterdam-based app-only supermarket startup intends to do…
There are multiple benefits of buying fresh, locally-sourced groceries like supporting local produce growers and helping small-scale suppliers.
The economy of building technology — markets, startups, capital flows, and the operating decisions behind ambitious companies.
8,345 articles · Business
There are multiple benefits of buying fresh, locally-sourced groceries like supporting local produce growers and helping small-scale suppliers.
APICBASE, the international supplier of cloud-based food management software, announces that it has received € 1.5 million in growth capital in an investment round led by Newion, who also invested in Brussel-based enterprise data governance, Collibra.
ValueBlue, the Utrecht-based SaaS supplier that increases its customers’ success by providing insight into relationships between data, IT and business, today announces it has received financing of two million euros from Newion Investments.
LemonOne, Germany’s on-demand photos startup has got a growth capital to drive vertical and international expansion.
Cancer is one of the most deadly diseases and is said to affect one in three people in western world.
Last mile ride sharing is a really competitive segment with multiple players trying to get a bigger chunk of the market.
Facebook just stepped into the cryptocurrency race by announcing its own digital currency called Libra.
The UK-based travel startup Duffel has made a major funding announcement of securing €19.2 million in its Series A funding round.
ArtiQ, an innovative spin-off startup of KU Leuven (Belgium) which helps doctors diagnose, treat and monitor respiratory problems has announced that it has successfully concluded its seed financing round, raising € 1 million.
London startup Zego is an insurtech startup specialising in flexible insurance.
Nowadays, we get everything including clothes, furniture, packages and even food delivered right to our doorsteps.
Imcyse, a developer of active specific immunotherapies for the treatment and prevention of severe chronic diseases, recently announced that it has raised €35 million ($39.5M) in a Series B financing round and through other channels.